Suppr超能文献

IgV(H)和bcl6体细胞突变分析揭示了皮肤B细胞淋巴瘤的异质性,并表明存在未公开的局部抗原。

IgV(H) and bcl6 somatic mutation analysis reveals the heterogeneity of cutaneous B-cell lymphoma, and indicates the presence of undisclosed local antigens.

作者信息

Franco Renato, Camacho Francisca I, Fernández-Vázquez Amalia, Algara Patrocinio, Rodríguez-Peralto José L, De Rosa Gaetano, Piris Miguel A

机构信息

Istituto dei Tumori G Pascale, Napoli, Italy.

出版信息

Mod Pathol. 2004 Jun;17(6):623-30. doi: 10.1038/modpathol.3800106.

Abstract

Our understanding of the ontology of B-cell lymphomas (BCL) has been improved by the study of mutational status of IgV(H) and bcl6 genes, but only a few cases of cutaneous BCL have been examined for this status. We analyzed IgV(H) and bcl6 somatic mutations in 10 cutaneous BCL, classified as follicular (three primary and one secondary), primary marginal zone (two cases), and diffuse large BCL (three primary and one secondary). We observed a lower rate (<2%) of IgV(H) mutation in all marginal zone lymphomas, and a preferential usage of V(H)2-70 (one primary follicular and two primary diffuse large BCL). Fewer than expected replacement mutations in framework regions (FR) were observed in three primary follicular lymphomas (FLs) and in all diffuse large BCL, indicating a negative antigen selection pressure. Ongoing mutations were observed in eight of 10 cases. Only two primary FLs and two diffuse large BCL showed bcl6 somatic mutation. These data support the heterogeneous nature of the different cutaneous BCL, and specifically the distinction between cutaneous follicular and marginal zone lymphomas. The biased usage of V(H)2-70, the low rate of replacement mutation in the FR, and the presence of ongoing mutation imply that local antigens could modulate the growth of primary cutaneous BCL.

摘要

通过对IgV(H)和bcl6基因的突变状态进行研究,我们对B细胞淋巴瘤(BCL)的本体论有了更深入的了解,但仅有少数皮肤BCL病例接受了该状态检测。我们分析了10例皮肤BCL中IgV(H)和bcl6的体细胞突变情况,这些病例分类为滤泡性(3例原发性和1例继发性)、原发性边缘区(2例)以及弥漫性大B细胞淋巴瘤(3例原发性和1例继发性)。我们观察到所有边缘区淋巴瘤中IgV(H)突变率较低(<2%),并且优先使用V(H)2-70(1例原发性滤泡性和2例原发性弥漫性大B细胞淋巴瘤)。在3例原发性滤泡性淋巴瘤(FL)和所有弥漫性大B细胞淋巴瘤中,框架区(FR)中替换突变数量少于预期,这表明存在负性抗原选择压力。10例中有8例观察到正在进行的突变。仅有2例原发性FL和2例弥漫性大B细胞淋巴瘤显示出bcl6体细胞突变。这些数据支持了不同皮肤BCL的异质性,特别是皮肤滤泡性和边缘区淋巴瘤之间的区别。V(H)2-70的偏向性使用、FR中替换突变率较低以及正在进行的突变表明,局部抗原可能调节原发性皮肤BCL的生长。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验